Irbesartan Heumann (Irbesartan)

Irbesartan blocks the angiotensin II type 1 (AT1) receptors, preventing angiotensin II from causing blood‑vessel constriction and aldosterone release. This leads to vasodilation, reduced sodium and water retention, and ultimately lower blood pressure and renal protection.

The appropriate dose of Irbesartan Heumann is determined by the prescribing clinician based on the patient’s blood‑pressure goals, kidney function and overall health. Dosage may be adjusted during treatment to achieve optimal control.

Irbesartan belongs to a class of medicines that are generally avoided during pregnancy because they can affect fetal development. Safety during breastfeeding has not been established, so the drug should be used only if the potential benefit outweighs the risk and after consulting a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Irbesartan, as an ARB, offers blood‑pressure reduction similar to ACE inhibitors but with a lower incidence of cough and angioedema. Compared with calcium‑channel blockers or diuretics, ARBs act on the renin‑angiotensin system, providing additional renal‑protective benefits especially in diabetic patients.

Irbesartan Heumann tablets should be stored at ambient temperature, below 25 °C, in the original container. Keep them away from moisture, direct sunlight and excessive heat to maintain product stability.

Irbesartan Heumann is taken orally, usually once daily, with or without food. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically instructed by a healthcare professional.

Serious risks include angioedema (swelling of the face, lips, tongue or throat), severe hypotension, acute kidney injury and hyperkalaemia. Patients should seek immediate medical attention if they experience swelling, dizziness, rapid weight gain, or persistent high potassium levels.

Irbesartan Heumann should not be used by individuals with known hypersensitivity to irbesartan or other ARBs, pregnant women, or patients with severe hepatic impairment unless specifically advised by a physician. Caution is also advised in those with advanced kidney disease or uncontrolled hyperkalaemia.